Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Orchid Pharma Ltd Financial Statements & Historical Data

Updated
Report details
Last Updated:
Author: |Social: XLinkedIn
COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 28 September 2026, 9:13 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price1,023₹ per share
Reported P/E339Times
Book value per share300₹ per share
Reported ROCE1.86 %%
Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Stored market and accounting figures

Price record: 28 September 2026, 9:13 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap6,129 Cr.
Current Price1,023
High / Low1,144/471
Stock P/E339
Book Value300
Dividend Yield0.00 %
ROCE1.86 %
ROE1.49 %
Face Value10.0

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Orchid Pharma Ltd 6,129 Cr. 1,023 1,144/471339 3000.00 %1.86 %1.49 % 10.0
IOL Chemicals & Pharmaceuticals Ltd 5,760 Cr. 196 219/67.132.6 61.30.51 %11.3 %8.42 % 2.00
Morepen Laboratories Ltd 6,611 Cr. 121 127/33.056.3 22.80.17 %8.05 %5.33 % 2.00
FDC Ltd 5,593 Cr. 344 476/31318.2 1531.46 %15.4 %11.2 % 1.00
Gujarat Themis Biosyn Ltd 5,170 Cr. 398 479/225106 26.40.17 %18.1 %17.4 % 1.00
Industry Average17,774.69 Cr1,258.9655.96211.600.38%26.16%16.59%6.06

All Competitor Stocks of Orchid Pharma Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 160210182.92198.76220.59217.10244.41222.70217.34237.48263.19193.52207.27368.33304.17
Expenses 146170160.78175.46185.21188.19211.92192.36190.97209.49268.84194.99205.71338.17290.17
Operating Profit 144022.1423.3035.3828.9132.4930.3426.3727.99-5.65-1.471.5630.1614.00
OPM % 9%19%12.10%11.72%16.04%13.32%13.29%13.62%12.13%11.79%-2.15%-0.76%0.75%8.19%4.60%
Other Income 9341.898.367.6213.367.577.528.493.9011.5710.77-1.507.551.83
Interest 875.553.803.543.473.503.333.803.922.283.733.181.962.23
Depreciation 877.717.849.278.428.448.638.618.8710.538.909.0310.9010.95
Profit before tax 75910.7720.0230.1930.3828.1225.9022.4519.10-6.89-3.33-12.1524.852.65
Tax % 0%0%0.00%0.00%0.00%-10.27%-0.53%0.00%0.00%-0.21%0.00%0.00%0.00%0.00%2.64%
Net Profit 8599.4019.8029.4332.9629.3527.2420.7822.29-5.69-5.72-12.6125.843.22
EPS in Rs 1.8614.491.853.905.806.505.795.374.104.39-1.12-1.13-2.495.090.63

Last Updated: September 28, 2026, 9:13 pm

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Sep 2013 covers 18 months; Mar 2015 covers 18 months. Values for periods of different lengths are not directly comparable.

Chart loads as you scroll. Values are available in the table.

All reported periods

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Sep 2013 covers 18 months; Mar 2015 covers 18 months. Values for periods of different lengths are not directly comparable.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: September 28, 2026, 9:13 pm

MetricSep 2013 (18 months)Mar 2015 (18 months)Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 1,9481,7478737976836004844505606668191,3981,2331,073
Expenses 1,8371,4297037946596125154215055817081,2471,1851,029
Operating Profit 110317171324-12-312955841111514844
OPM % 6%18%20%0.4%3.6%-2.0%-6%7%10%13%14%11%3.9%4.1%
Other Income 92156-28-59202182415675231261519
Interest 523537294347310765233331713911
Depreciation 252325145141133130118109875533424340
Profit before tax -573-389-296-544-39969-131-117248921221012
Tax % -2%-49%-6%-9%-12%0%0%0%0%0%-3%-8%-2%
Net Profit -560-197-279-495-35369-131-117-246921351011
EPS in Rs -79.21-23.06-31.37-55.69-39.657.80-32.11-28.55-0.4811.3518.1726.631.962.10
Dividend Payout % 0%0%0%0%0%0%0%0%0%0%0%0%0%

YoY Net Profit Growth

Year2016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)-77.42%28.69%119.55%-289.86%10.69%98.29%2400.00%100.00%46.74%-92.59%
Change in YoY Net Profit Growth (%)0.00%106.11%90.86%-409.40%300.54%87.60%2301.71%-2300.00%-53.26%-139.33%

Orchid Pharma Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2016-2017 to 2025-2026.

Growth

Compounded Sales Growth
10 Years:-6%
5 Years:14%
3 Years:18%
TTM:-3%
Compounded Profit Growth
10 Years:9%
5 Years:23%
3 Years:249%
TTM:-24%
Stock Price CAGR
10 Years:30%
5 Years:Not available
3 Years:33%
1 Year:-51%
Return on Equity
10 Years:Not available
5 Years:2%
3 Years:7%
Last Year:8%

Last Updated: September 5, 2025, 11:55 am

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: September 26, 2026, 8:59 pm

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 858989898941414141511515
Reserves 244-40-556-881-7937256126076481,1191,4941,504
Borrowings 3,2113,2153,1063,2023,230566453268331135154307
Other Liabilities 521598616715551128132195205249414432
Total Liabilities 4,0613,8623,2563,1253,0771,4601,2371,1111,2251,5542,0772,258
Fixed Assets 1,7951,6371,4971,3861,256858670584573620708692
CWIP 28228028827227826710463181414
Investments 111100154544466067
Other Assets 1,9841,9441,4701,4671,5425765444725618571,2291,086
Total Assets 4,0613,8623,2563,1253,0771,4601,2371,1111,2251,5542,0772,258
FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + -3692124019128124921812651126
Cash from Investing Activity + 1,334-1-176-284516767113-31-312-36-277
Cash from Financing Activity + -597-286-46533-0-250-165-217311672137
Net Cash Flow 367-76-2401557-2-74-1118-1917-14
Free Cash Flow 965211392357723238-861-102-255
CFO/OP -102%124%13,628%67%-138%-226%63%173%22%113%44%259%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow965.00211.00392.003.005.0077.0023.00238.00-8.0061.00-102.00-255.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Returns on capital & equity

%

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthSep 2013Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 3454130756473511101111188796
Inventory Days 187118220196202214254244201217199219
Days Payable 220146341402374381182176195165173149
Cash Conversion Cycle -0269-130-108-94123179117170113166
Working Capital Days -399-49-168-500-876-1,1581663029754118135
ROCE %-3%1%1%-4%-4%-5%-6%-5%-2%5%9%8%
FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 72.40%69.84%69.84%69.84%69.84%69.84%69.84%69.84%69.84%69.84%69.84%69.84%
FIIs 8.08%4.14%1.96%1.42%1.94%2.53%2.69%1.39%1.56%1.17%0.87%0.80%
DIIs 12.46%14.51%17.73%18.93%18.30%19.00%20.10%19.43%19.04%19.38%20.24%20.75%
Public 7.05%11.52%10.47%9.82%9.94%8.63%7.37%9.34%9.57%9.61%9.04%8.62%
No. of Shareholders 29,19736,93136,72034,69536,36334,15834,30339,82738,15535,70935,11833,433
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Quant Small Cap Fund 3,465,947 0.88 242.31,534,9192025-12-07 17:25:17125.81%
Invesco India Contra Fund 990,763 0.35 69.26N/AN/AN/A
Kotak Multi Asset Allocation Fund 942,962 0.54 65.92689,0172026-02-21 15:51:0336.86%
UTI Value Fund 787,231 0.56 55.04745,2302026-02-23 01:48:215.64%
Invesco India Smallcap Fund 455,183 0.35 31.82N/AN/AN/A
Kotak Special Opportunities Fund 427,811 2.1 29.91N/AN/AN/A
Bandhan Small Cap Fund 310,553 0.11 21.71294,2012026-01-26 08:21:045.56%
UTI Small Cap Fund 283,362 0.44 19.81445,0002025-12-08 01:35:25-36.32%
Kotak Consumption Fund 266,000 1.13 18.6N/AN/AN/A
Kotak Multicap Fund 264,308 0.08 18.48114,3082026-01-25 05:51:32131.22%

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 19.6519.0611.35-0.48-28.55
Diluted EPS (Rs.) 19.6519.0611.35-0.48-28.55
Cash EPS (Rs.) 25.6925.3025.3021.71-1.87
Book Value[Excl.RevalReserv]/Share (Rs.) 249.86230.58168.72158.61159.96
Book Value[Incl.RevalReserv]/Share (Rs.) 249.86230.58168.72158.61159.96
Revenue From Operations / Share (Rs.) 181.77161.55163.14137.09110.26
PBDIT / Share (Rs.) 28.5227.9125.2515.2215.93
PBIT / Share (Rs.) 21.7121.3511.82-6.10-10.76
PBT / Share (Rs.) 18.8418.1313.54-13.94-23.34
Net Profit / Share (Rs.) 18.8818.7411.880.38-28.55
NP After MI And SOA / Share (Rs.) 19.6518.1711.35-0.47-28.55
PBDIT Margin (%) 15.6917.2715.4711.1014.44
PBIT Margin (%) 11.9413.217.24-4.44-9.75
PBT Margin (%) 10.3611.228.29-10.16-21.16
Net Profit Margin (%) 10.3811.607.270.28-25.89
NP After MI And SOA Margin (%) 10.8011.246.95-0.34-25.89
Return on Networth / Equity (%) 7.867.886.72-0.30-17.84
Return on Capital Employeed (%) 7.858.375.65-2.86-4.00
Return On Assets (%) 5.905.933.78-0.17-9.41
Long Term Debt / Equity (X) 0.100.100.210.320.65
Total Debt / Equity (X) 0.130.110.480.410.65
Asset Turnover Ratio (%) 0.560.580.570.470.30
Current Ratio (X) 2.833.041.351.873.87
Quick Ratio (X) 1.682.030.731.152.79
Inventory Turnover Ratio (X) 3.122.142.022.091.60
Interest Coverage Ratio (X) 9.958.653.201.941.27
Interest Coverage Ratio (Post Tax) (X) 7.596.811.50-0.77-0.85
Enterprise Value (Cr.) 3934.975169.071869.701420.3010472.28
EV / Net Operating Revenue (X) 4.276.312.812.5423.27
EV / EBITDA (X) 27.2036.5218.1422.86161.10
MarketCap / Net Operating Revenue (X) 4.276.472.362.0722.36
Price / BV (X) 3.114.532.281.7915.41
Price / Net Operating Revenue (X) 4.276.472.362.0722.36
EarningsYield 0.020.010.020.00-0.01
Advertisements
Explore Industry-wise Company financial data